中药板块9月16日涨0.04%，维康药业领涨，主力资金净流出6.92亿元

Market Overview - On September 16, the Chinese medicine sector rose by 0.04% compared to the previous trading day, with Weikang Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3861.87, up 0.04%, while the Shenzhen Component Index closed at 13063.97, up 0.45% [1] Top Gainers in Chinese Medicine Sector - Weikang Pharmaceutical (300878) closed at 23.80, with an increase of 8.23% and a trading volume of 86,600 shares, amounting to a transaction value of 201 million yuan [1] - Renhe Pharmaceutical (000650) closed at 6.73, up 5.49%, with a trading volume of 1.3482 million shares and a transaction value of 899 million yuan [1] - Panlong Pharmaceutical (002864) closed at 31.21, increasing by 3.52%, with a trading volume of 94,600 shares and a transaction value of 293 million yuan [1] Top Losers in Chinese Medicine Sector - ST Changyao (300391) closed at 4.00, down 1.72%, with a trading volume of 85,400 shares and a transaction value of 34.11 million yuan [2] - Kangyuan Pharmaceutical (600557) closed at 16.05, down 1.41%, with a trading volume of 117,500 shares and a transaction value of 189 million yuan [2] - Lingrui Pharmaceutical (600285) closed at 22.55, down 1.10%, with a trading volume of 89,100 shares and a transaction value of 201 million yuan [2] Capital Flow Analysis - The Chinese medicine sector experienced a net outflow of 690 million yuan from institutional investors, while retail investors saw a net inflow of 569 million yuan [2] - The top stocks with significant net inflows from retail investors include Shanghai Kaibao (300039) with a net inflow of 17.84 million yuan [3] - Guizhou Sanli (603439) also saw a net inflow of 17.76 million yuan from retail investors [3]